肉桂醛抗人宫颈癌相关机制的研究

目的探讨不同浓度的肉桂醛对HeLa细胞P21、CDK4蛋白表达的影响及意义。方法不同浓度的经过纯度鉴定的肉桂醛处理体外培养的HeLa细胞,培养24 h后免疫组织化学和Western blotting法检测HeLa细胞P21、CDK4蛋白表达的变化。结果肉桂醛纯度〉96.24%;肉桂醛能显著增高P21和降低CDK4蛋白在HeLa细胞中的表达,各浓度肉桂醛处理组的P21、CDK4蛋白表达与溶剂对照组相比差异均有统计学意义（P〈0.01,P〈0.05）。结论肉桂醛能上调宫颈癌HeLa细胞P21蛋白表达和下调CDK4蛋白表达,可能是促进HeLa细胞凋亡的机制之一。     

华山新麦草叶片的光合生理特性

对华山新麦草(Psathyrostachys huashanica Keng ex P.C.Kuo)营养叶的净光合速率(Pn)和蒸腾速率(Tr)的日变化曲线进行了分析,并在对叶温(Tl)、气孔阻力(Rs)、光合有效辐射强度(PAR)和气温(Ta)的日变化曲线进行测定的基础上分析了它们对华山新麦草Pn的影响规律。结果表明:华山新麦草Pn的日变化曲线呈"三峰"型,峰值分别为6.5、6.2和9.0μmol.m-2.s-1,依次出现在9:30、11:30和16:30,而且具有明显的"午降"现象;Tr的日变化曲线呈"单峰"型,最大值为1.7 mmol.m-2.s-1,出现在13:30;Tl、Rs、PAR和Ta的日变化曲线均呈"单峰"型,峰值分别出现在12:30、11:30、12:30和13:30。华山新麦草的Pn对Tl、PAR和Ta的响应曲线均呈"抛物线"型,Pn在一定范围内与Tl、PAR和Ta呈正相关,随着Tl、PAR和Ta的升高逐渐增加至最大值后逐渐降低;而Pn与Rs则呈负相关,Pn在一定范围内随Rs的增大逐渐降低。根据拟合方程,华山新麦草营养叶的光补偿点和光饱和点分别为1.1和531.5μmol.m-2.s-1,说明该种类具有很强的喜光性,且对光照强度的适应范围较广。研究结果表明:较大的气孔阻力是造成华山新麦草叶片净光合速率偏低的主要原因。     

家蚕核型多角体病毒BmNPV囊膜蛋白P74膜外区克隆和原核表达

通过PCR扩增家蚕核型多角体病毒(Bombyx mori nucleopolyhedrovirus,BmNPV)囊膜蛋白p74基因膜外区片段,对切胶纯化得到的DNA目的片段与原核表达载体pET28a进行连接,通过不同浓度的IPTG对含有pET28a-p74重组质粒的大肠杆菌BL21(DE3)进行诱导,对诱导产物进行SDS-PAGE电泳.结果表明p74基因膜外区获得了表达;通过His单抗对原核表达产物进行Western blotting分析,其结果证实诱导蛋白带为融合有组氧酸的目的蛋白.对割胶获得的P74蛋白和免疫佐剂进行克分研磨,以研磨后的匀浆液对昆明小鼠进行皮下多点注射,通过收获的抗血清对BmNPV ODV病毒粒子进行Westem blotting分析,检测到一条分子量大小为74 kD的特异杂交带,表明获得的多抗可用于P74蛋白功能的进一步研究.     

用P. pastoris的pAOX1表达系统表达木糖异构酶

目的:应用P. pastoris的pAOX1表达系统分泌表达重组木糖异构酶.方法:用PCR法从大肠杆菌基因组中扩增木糖异构酶基因(xi).用EcoRⅠ和NotⅠ双酶切将其基因克隆进P. pastoris表达载体.通过电转法将其木糖异构酶基因重组于P. pastoris基因组,筛选G418抗性700μg/ml的重组子作为工程菌GS115(pPIC9K-xi).在摇瓶中发酵用甲醇诱导表达重组木糖异构酶.用SDS-PAGE分析重组蛋白的表达情况,用糖酵解法对表达产物进行活性分析.结果:木糖异构酶基因在pAOX1的调控下,在P. pastoris中经甲醇诱导能分泌表达,摇瓶发酵2d表达量为35mg/L,表达产物具有代谢木糖的作用.结论:成功地克隆了大肠杆菌的木糖异构酶基因,并实现用pAOX1系统在P. pastoris中表达中木糖异构酶,为用P. pastoris规模化生产重组木糖异构酶奠定了基础.     

An introduction to biological nuclear magnetic resonance spectroscopy

Nuclear magnetic resonance (NMR) spectroscopy is one of the most powerful analytical techniques available to biology. This review is an introduction to the potential of this method and is aimed at readers who have little or no experience in acquiring or analyzing NMR spectra. We focus on spectroscopic applications of the magnetic resonance effect, rather than imaging ones, and explain how various aspects of the NMR phenomenon make it a versatile tool with which to address a number of biological problems. Using detailed examples, we discuss the use of ¹H NMR spectroscopy in mixture analysis and metabolomics, the use of ¹³C NMR spectroscopy in tracking isotopomers and determining the flux through metabolic pathways (‘fluxomics’) and the use of ³¹P NMR spectroscopy in monitoring ATP generation and intracellular pH homeotasis in vivo. Further examples demonstrate how NMR spectroscopy can be used to probe the physical environment of a cell by measuring diffusion and the tumbling rates of individual metabolites and how it can determine macromolecular structures by measuring the bonds and distances which separate individual atoms. We finish by outlining some of the key challenges which remain in NMR spectroscopy and we highlight how recent advances—such as increased magnet field strengths, cryogenic cooling, microprobes and hyperpolarisation—are opening new avenues for today's biological NMR spectroscopists.     

Expression of P2Y receptors in the rat anterior pituitary

In this study, the distribution patterns of P2Y₁, P2Y₂ P2Y₄, P2Y₆, P2Y₁₂, and P2Y₁₃ receptors in the anterior pituitary cells of rat were studied with double-labeling immunofluorescence and Western blot. The results showed that P2Y receptors were widely expressed in the anterior pituitary. P2Y₁ and P2Y₄ receptors were found to be expressed in the majority of gonadotrophs and thyrotrophs, P2Y₂ receptors were expressed in a small subpopulation of lactotrophs and almost all the folliculo-stellate cells, that were also stained with S100 protein immunoreactivity. P2Y₆ receptors were expressed in macrophages. P2Y₁₃ receptors were expressed in a small subpopulation of cells in the rat anterior pituitary, the identity of which needs to be clarified. P2Y₁ and P2Y₄ receptors are co-expressed in some gonadotrophs and thyrotrophs. Corticotrophs and somatotrophs were found not to express P2Y receptors in this study. FSH and TSH were shown to coexist in the same endocrine cells in rat anterior pituitary. The present data suggests that purines and/or pyrimidines could be involved in regulating the functions of gonadotrophs and thyrotrophs via P2Y₁ and P2Y₄ receptors, some lactotrophs via P2Y₂ receptors, and folliculo-stellate cells via P2Y₂ receptors in the rat anterior pituitary.     

C terminus of the P2X7 receptor: treasure hunting

P2X receptor (P2XR) is a family of the ATP-gated ion channel family and can permeabilize the plasma membrane to small cations such as potassium, sodium, and calcium, resulting in cellular depolarization. There are seven P2XR that have been described and cloned, with 45% identity in amino acid sequence. Each P2X receptors has two transmembrane domains that are separated by an extracellular loop and an intracellular N and C terminus. Unlike the other P2X receptors, the P2X7R has a larger C terminus with an extra 200 amino acid residues compared with the other receptors. The C terminus of the P2X7R has been implicated in regulating receptor function including signaling pathway activation, cellular localization, protein–protein interactions, and post-translational modification (PTM). In the present review, we discuss the role of the P2X7R C terminus in regards to receptor function, describe the specific domains and motifs found therein and compare the C terminus sequence with others proteins to discover predicted domains or sites of PTM.     

The P2X1 receptor and platelet function

Extracellular nucleotides are ubiquitous signalling molecules, acting via the P2 class of surface receptors. Platelets express three P2 receptor subtypes, ADP-dependent P2Y1 and P2Y12 G-protein-coupled receptors and the ATP-gated P2X1 non-selective cation channel. Platelet P2X1 receptors can generate significant increases in intracellular Ca²⁺, leading to shape change, movement of secretory granules and low levels of α_IIbβ₃ integrin activation. P2X1 can also synergise with several other receptors to amplify signalling and functional events in the platelet. In particular, activation of P2X1 receptors by ATP released from dense granules amplifies the aggregation responses to low levels of the major agonists, collagen and thrombin. In vivo studies using transgenic murine models show that P2X1 receptors amplify localised thrombosis following damage of small arteries and arterioles and also contribute to thromboembolism induced by intravenous co-injection of collagen and adrenaline. In vitro, under flow conditions, P2X1 receptors contribute more to aggregate formation on collagen-coated surfaces as the shear rate is increased, which may explain their greater contribution to localised thrombosis in arterioles compared to venules within in vivo models. Since shear increases substantially near sites of stenosis, anti-P2X1 therapy represents a potential means of reducing thrombotic events at atherosclerotic plaques.